Literature DB >> 30326145

Should Ki67 immunohistochemistry be performed on all lesions in multifocal small intestinal neuroendocrine tumours?

Numbereye Numbere1, Aaron R Huber1, Chanjuan Shi2, Justin M M Cates2, Raul S Gonzalez1.   

Abstract

AIMS: Well-differentiated small intestinal neuroendocrine tumours (SI-NETs) are often multifocal, and this has been suggested to impart worse disease-free survival. Practice guidelines have not been established for World Health Organisation (WHO) grading of multiple primary lesions. METHODS AND
RESULTS: We identified 68 patients with ileal/jejunal SI-NET for a combined total of 207 primary lesions. Each case was evaluated for patient age and sex; size of all tumours; presence of lymph node metastases, mesenteric tumour deposits or distant metastases; and disease-specific outcome. Ki67 staining was performed on all 207 primary lesions. The relationship between multifocality and clinicopathological factors was compared using Fisher's exact test. Outcome was tested using Cox proportional hazard regression. Forty-two patients had unifocal disease, and 26 had multifocal disease (median five lesions, range = 2-32). Most tumours were WHO grade 1 (201 of 207, 97%). Of the five patients with grades 2/3 tumours, three patients had unifocal disease, one patient had two subcentimetre grade 2 lesions (including the largest) and eight subcentimetre grade 1 lesions, and one patient had one 1.6-cm grade 3 lesion and one subcentimetre grade 1 lesion. There was a positive correlation between tumour size and Ki67 index (coefficient 0.28; 95% confidence interval 0.05-0.52, P = 0.017). There was no significant association between multifocality and nodal metastases, mesenteric tumour deposits, distant metastases or disease-specific survival.
CONCLUSIONS: In patients with multifocal SI-NET, unless a particular lesion has a high mitotic rate, only staining the largest lesion for Ki67 should serve to grade almost all cases accurately. Multifocality does not appear to significantly impact patient survival.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Ki67; grading; multifocality; neuroendocrine tumour; small bowel

Mesh:

Substances:

Year:  2018        PMID: 30326145     DOI: 10.1111/his.13771

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  3 in total

1.  Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery.

Authors:  Anna Pozza; Bruno Pauletti; Marco Scarpa; Cesare Ruffolo; Nicolò Bassi; Marco Massani
Journal:  Int J Colorectal Dis       Date:  2019-09-13       Impact factor: 2.571

2.  Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask.

Authors:  Manuela Albertelli; Federica Grillo; Fabio Lo Calzo; Giulia Puliani; Carmen Rainone; Annamaria Anita Livia Colao; Antongiulio Faggiano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

3.  Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine Tumours.

Authors:  Moritz Jesinghaus; Jelte Poppinga; Bettina Lehman; Elisabeth Maurer; Annette Ramaswamy; Albert Grass; Pietro Di Fazio; Anja Rinke; Carsten Denkert; Detlef K Bartsch
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.